El Ahlyia offers the cardiology surgical market with LivaNova devices, the global leader in manufacturing and supply solution to manage heart valve defects through offering truly suture less Aortic heart valve replacement in addition to tricuspid and Mitral valves.
The neuromodulation solution of LivaNova extend treatment option to drug-resistant Epilepsy and resistant depression patients through pioneered Vagus Nerve Stimulation Therapy System (VNS).
El Ahlyia has additionally succeeded in earning the valuable confidence of Rontis Vascular as its trusted representative in the Egyptian market, while building on our prolific cooperation with Covidien and IHT.
The neuromodulation solution of LivaNova extend treatment option to drug-resistant Epilepsy and resistant depression patients through pioneered Vagus Nerve Stimulation Therapy System (VNS).
El Ahlyia has additionally succeeded in earning the valuable confidence of Rontis Vascular as its trusted representative in the Egyptian market, while building on our prolific cooperation with Covidien and IHT.
